Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Prybylski

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceutics|December 5, 2013
The Flux of Phenolic Compounds through Silicone MembranesJohn Prybylski, Kenneth B Sloan
Therapeutic Delivery|May 27, 2014
Flux through silicone and human skin fitted to a series/parallel modelJohn Prybylski, Kenneth B Sloan
ACS Biomaterials Science & Engineering|January 12, 2021
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O BackboneJustin McCallen, John Prybylski, Qi Yang, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose SelectionYeamin Huh, Ruolun Qiu, John Prybylski, et al.
Clinical Pharmacology in Drug Development|May 22, 2025
Pharmacokinetics, Safety, and Tolerability of Single-Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double-Blind, Phase 1 StudiesNaihan Chen, Yamato Sano, Xiaohong Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2024
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, et al.
Iscience|June 6, 2022
The <i>ex vivo</i> pharmacology of HIV-1 antiretrovirals differs between macaques and humansCarolina Herrera, Mackenzie L Cottrell, John Prybylski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceutics|December 5, 2013
The Flux of Phenolic Compounds through Silicone MembranesJohn Prybylski, Kenneth B Sloan
Therapeutic Delivery|May 27, 2014
Flux through silicone and human skin fitted to a series/parallel modelJohn Prybylski, Kenneth B Sloan
ACS Biomaterials Science & Engineering|January 12, 2021
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O BackboneJustin McCallen, John Prybylski, Qi Yang, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose SelectionYeamin Huh, Ruolun Qiu, John Prybylski, et al.
Clinical Pharmacology in Drug Development|May 22, 2025
Pharmacokinetics, Safety, and Tolerability of Single-Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double-Blind, Phase 1 StudiesNaihan Chen, Yamato Sano, Xiaohong Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2024
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, et al.
Iscience|June 6, 2022
The <i>ex vivo</i> pharmacology of HIV-1 antiretrovirals differs between macaques and humansCarolina Herrera, Mackenzie L Cottrell, John Prybylski, et al.
Pageof 1